Siemens Healthineers misses Q3 forecasts due to slow China
Writes through with shares, CEO and CFO comments from call
By Marleen Kaesebier and Louis van Boxel-Woolf
July 31 (Reuters) -German medical technology company Siemens Healthineers SHLG.DE said on Wednesday its sales were hit by continued order delays in China in the third quarter, sending its shares more than 6% lower.
Healthcare technology companies are grappling with China's anti-corruption campaign that has made promotional and sales activities harder in the country.
Siemens Healthineers reported a revenue of 5.42 billion euros ($5.87 billion) for the third quarter, while analysts had expected 5.54 billion on average in a poll by Vara Research.
Revenue grew across its other markets, but declined 13% on a comparable basis in China due to temporary delays in orders, it said.
Dutch Peer Philips PHG.AS also reported lower half-year sales in China on Monday, citing the anti-corruption campaign.
Siemens Healthineers' CEO Bernd Montag said on a call that he expected the orders delayed by the campaign to materialise as soon as 2025.
"Structural demand in China is completely intact," Montag said, adding business in the country should stabilise in the fourth quarter.
The company expects more orders for its CT and MRI products from Chinese hospitals and healthcare facilities over the next fiscal year, he said.
It said it had seen signs of China preparing a government stimulus programme to boost investments in the healthcare system, which should help med-tech companies once implemented.
"The question remains when will China improve," Jefferies analysts said in a note, adding an improvement from here would be critical to back the 2025 estimates.
Sales in the group's Medical Imaging unit, which makes up about 55% of its revenue, declined by a low double-digit percentage in China, it said.
The company lowered its revenue outlook for the unit, expecting it to grow by 4.5% to 5.5% this year, compared with the previous forecast of 6% to 8%.
On the group level, annual sales growth is expected to come at the lower end of the guidance range of 4.5% to 6.5%, CFO Jochen Schmitz said during the call.
($1 = 0.9239 euros)
Reporting by Marleen Kaesebier and Louis van Boxel-Woolf in Gdansk and Alexander Hübner in Munich; Editing by Milla Nissi
Aset Berkaitan
Berita Terkini
Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.
Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.
Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.
